The clinical behaviour of ovarian tumours of low malignant potential (LMP) is unpredictable and it has been suggested that the majority of these lesions have no invasive potential. This study has analysed 92 epithelial ovarian tumours [11 mucinous cystadenomas, 18 mucinous LMP tumours, 15 mucinous carcinomas (9 FIGO stage I), 16 serous cystadenomas, 15 serous LMP tumours, and 17 serous carcinomas (11 FIGO stage I)] for numerical abnormalities of chromosomes 1, 11, 17, and X by interphase cytogenetics. Overall, numerical aberrations were identified in none of the cystadenomas, 15 per cent of serous LMP tumours, 17 per cent of mucinous LMP tumours, 67 per cent of mucinous carcinomas, and 82 per cent of invasive serous carcinomas. In mucinous ...
Scant cytogenetic data are available for ovarian malignant germ cell tumors (MOGCT) when compared wi...
As a prelude to assessing the relationship of chromosome alterations to clinical outcome in ovarian ...
Background According to the scientific literature, less than 30 borderline ovarian t...
The clinical behaviour of ovarian tumours of low malignant potential (LMP) is unpredictable and it h...
In this report we present the characterization of ovarian neoplasms including benign tumors, borderl...
In this study, 23 low malignant potential (LMP) and 27 invasive epithelial ovarian tumours have been...
Objective(s): The aim of this study was to examine the expression of the antimetastasis gene nm23 an...
The molecular events that give rise to ovarian epithelial neoplasms are not well understood. In part...
Ovarian carcinomas exhibit extensive heterogeneity, and their etiology remains unknown. Histological...
The phenotypic variability of epithelial ovarian neoplasms correlates with a diversity of changes at...
Purpose: Serous ovarian carcinomas are the predominant epithelial ovarian cancer subtype and it has ...
Sporadic ovarian cancer is a particularly aggressive tumor characterized by highly abnormal karyotyp...
Twenty malignant effusions secondary to ovarian cancer have been cytogenetically analyzed directly a...
Cytogenetic analysis was performed on short-term cultures of primary ovarian carcinomas from 62 pati...
Summary Microsatellite instability has been observed in a variety of sporadic malignancies, but its ...
Scant cytogenetic data are available for ovarian malignant germ cell tumors (MOGCT) when compared wi...
As a prelude to assessing the relationship of chromosome alterations to clinical outcome in ovarian ...
Background According to the scientific literature, less than 30 borderline ovarian t...
The clinical behaviour of ovarian tumours of low malignant potential (LMP) is unpredictable and it h...
In this report we present the characterization of ovarian neoplasms including benign tumors, borderl...
In this study, 23 low malignant potential (LMP) and 27 invasive epithelial ovarian tumours have been...
Objective(s): The aim of this study was to examine the expression of the antimetastasis gene nm23 an...
The molecular events that give rise to ovarian epithelial neoplasms are not well understood. In part...
Ovarian carcinomas exhibit extensive heterogeneity, and their etiology remains unknown. Histological...
The phenotypic variability of epithelial ovarian neoplasms correlates with a diversity of changes at...
Purpose: Serous ovarian carcinomas are the predominant epithelial ovarian cancer subtype and it has ...
Sporadic ovarian cancer is a particularly aggressive tumor characterized by highly abnormal karyotyp...
Twenty malignant effusions secondary to ovarian cancer have been cytogenetically analyzed directly a...
Cytogenetic analysis was performed on short-term cultures of primary ovarian carcinomas from 62 pati...
Summary Microsatellite instability has been observed in a variety of sporadic malignancies, but its ...
Scant cytogenetic data are available for ovarian malignant germ cell tumors (MOGCT) when compared wi...
As a prelude to assessing the relationship of chromosome alterations to clinical outcome in ovarian ...
Background According to the scientific literature, less than 30 borderline ovarian t...